|
1
|
Jemal A, Bray F, Center MM, Ferlay J, Ward
E and Forman D: Global cancer statistics. CA Cancer J Clin.
61:69–90. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Gramantieri L, Fornari F, Callegari E,
Sabbioni S, Lanza G, Croce CM, Bolondi L and Negrini M: MicroRNA
involvement in hepatocellular carcinoma. J Cell Mol Med.
12:2189–2204. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Rich N and Singal AG: Hepatocellular
carcinoma tumour markers: Current role and expectations. Best Pract
Res Clin Gastroenterol. 28:843–853. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Yang X, Xie X, Xiao YF, Xie R, Hu CJ, Tang
B, Li BS and Yang SM: The emergence of long non-coding RNAs in the
tumorigenesis of hepatocellular carcinoma. Cancer Lett.
360:119–124. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Li C, Chen J, Zhang K, Feng B, Wang R and
Chen L: Progress and prospects of long noncoding RNAs (lncRNAs) in
hepatocellular carcinoma. Cell Physiol Biochem. 36:423–434. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Qu Z, Yuan CH, Yin CQ, Guan Q, Chen H and
Wang FB: Meta-analysis of the prognostic value of abnormally
expressed lncRNAs in hepatocellular carcinoma. Onco Targets Ther.
9:5143–5152. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Shi L, Peng F, Tao Y, Fan X and Li N:
Roles of long noncoding RNAs in hepatocellular carcinoma. Virus
Res. 223:131–139. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Yan TH, Yang H, Jiang JH, Lu SW, Peng CX,
Que HX, Lu WL and Mao JF: Prognostic significance of long
non-coding RNA PCAT-1 expression in human hepatocellular carcinoma.
Int J Clin Exp Pathol. 8:4126–4131. 2015.PubMed/NCBI
|
|
9
|
Li T, Xie J, Shen C, Cheng D, Shi Y, Wu Z,
Deng X, Chen H, Shen B, Peng C, et al: Amplification of long
noncoding RNA ZFAS1 promotes metastasis in hepatocellular
carcinoma. Cancer Res. 75:3181–3191. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Wang F, Xie C, Zhao W, Deng Z, Yang H and
Fang Q: Long non-coding RNA CARLo-5 expression is associated with
disease progression and predicts outcome in hepatocellular
carcinoma patients. Clin Exp Med. 17:33–43. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Chang L, Li C, Lan T, Wu L, Yuan Y, Liu Q
and Liu Z: Decreased expression of long non-coding RNA GAS5
indicates a poor prognosis and promotes cell proliferation and
invasion in hepatocellular carcinoma by regulating vimentin. Mol
Med Rep. 13:1541–1550. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Bosman FT, Carneiro F, Hruban RH and
Theise ND: WHO classification of tumours of the digestive
systemFourth edition. Lyon: World Health Organization; pp. 205–227.
2010
|
|
13
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-delta delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
He Y, Meng XM, Huang C, Wu BM, Zhang L, Lv
XW and Li J: Long noncoding RNAs: Novel insights into hepatocelluar
carcinoma. Cancer Lett. 344:20–27. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Wan L, Kong J, Tang J, Wu Y, Xu E, Lai M
and Zhang H: HOTAIRM1 as a potential biomarker for diagnosis of
colorectal cancer functions the role in the tumour suppressor. J
Cell Mol Med. 20:2036–2044. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Yan H, Tian R, Zhang M, Wu J, Ding M and
He J: High expression of long noncoding RNA HULC is a poor
predictor of prognosis and regulates cell proliferation in glioma.
Onco Targets Ther. 10:113–120. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Zou JH, Li CY, Bao J and Zheng GQ: High
expression of long noncoding RNA Sox2ot is associated with the
aggressive progression and poor outcome of gastric cancer. Eur Rev
Med Pharmacol Sci. 20:4482–4486. 2016.PubMed/NCBI
|
|
18
|
Liu S, Xu B and Yan D: Enhanced expression
of long non-coding RNA Sox2ot promoted cell proliferation and
motility in colorectal cancer. Minerva Med. 107:279–286.
2016.PubMed/NCBI
|
|
19
|
Tang X, Gao Y, Yu L, Lu Y, Zhou G, Cheng
L, Sun K, Zhu B, Xu M and Liu J: Correlations between lncRNA-SOX2OT
polymorphism and susceptibility to breast cancer in a Chinese
population. Biomark Med. 11:277–284. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Shi XM and Teng F: Up-regulation of long
non-coding RNA Sox2ot promotes hepatocellular carcinoma cell
metastasis and correlates with poor prognosis. Int J Clin Exp
Pathol. 8:4008–4014. 2015.PubMed/NCBI
|
|
21
|
Zhou H, Wang F, Chen H, Tan Q, Qiu S, Chen
S, Jing W, Yu M, Liang C, Ye S and Tu J: Increased expression of
long-noncoding RNA ZFAS1 is associated with epithelial-mesenchymal
transition of gastric cancer. Aging (Albany NY). 8:2023–2038. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Li SP, Xu HX, Yu Y, He JD, Wang Z, Xu YJ,
Wang CY, Zhang HM, Zhang RX, Zhang JJ, et al: LncRNA HULC enhances
epithelial-mesenchymal transition to promote tumorigenesis and
metastasis of hepatocellular carcinoma via the miR-200a-3p/ZEB1
signaling pathway. Oncotarget. 7:42431–42446. 2016.PubMed/NCBI
|
|
23
|
Wang TH, Yu CC, Lin YS, Chen TC, Yeh CT,
Liang KH, Shieh TM, Chen CY and Hsueh C: Long noncoding RNA
CPS1-IT1 suppresses the metastasis of hepatocellular carcinoma by
regulating HIF-1α activity and inhibiting epithelial-mesenchymal
transition. Oncotarget. 7:43588–43603. 2016.PubMed/NCBI
|
|
24
|
Wang SH, Wu XC, Zhang MD, Weng MZ, Zhou D
and Quan ZW: Upregulation of H19 indicates a poor prognosis in
gallbladder carcinoma and promotes epithelial-mesenchymal
transition. Am J Cancer Res. 6:15–26. 2015.PubMed/NCBI
|
|
25
|
Dong L, Ni J, Hu W, Yu C and Li H:
Upregulation of long non-coding RNA PlncRNA-1 promotes metastasis
and induces epithelial-mesenchymal transition in hepatocellular
carcinoma. Cell Physiol Biochem. 38:836–846. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Khan MA, Chen HC, Zhang D and Fu J: Twist:
A molecular target in cancer therapeutics. Tumour Biol.
34:2497–2506. 2013. View Article : Google Scholar : PubMed/NCBI
|
